FrancophonIA/ELRC3.0 huggingface dataset:
English: It is worth noting that the withdrawal period for sheep meat for many of the products that fall within the scope of this procedure, including the generic product Tylovectin and the reference product Tylan 200 as authorised in France, is 42 days.
Estonian: Tuleb märkida, et selle menetluse mitme ravimi, sealhulgas geneerilise ravimi Tylovectin ja Prantsusmaal heaks kiidetud võrdlusravimi Tylan 200 keeluaeg lambaliha korral on 42 päeva.
English: Consequently, the CVMP is proposing to harmonise the milk withdrawal period to products concerned to 108 hours following the approached outlined in the guideline mentioned above.
Estonian: Veterinaarravimite komitee teeb seega ettepaneku ühtlustada eelnimetatud suunises kirjeldatud metoodikat arvestades asjaomaste ravimite keeluaeg piima korral 108 tunnile.
English: Hence, and in view of the limited data and considerations mentioned above, the Committee considered that harmonising the withdrawal periods of 49 out of 50 of the products concerned within the scope of this referral procedure, to a withdrawal period of 42 days for meat and offal from sheep, would be a conservative approach to ensure consumer safety (i.e., to ensure that residues at the injection site would be below the established MRL for tylosin meat (100 µg/kg)).
Estonian: Arvestades eespool nimetatud piiratud andmeid ja kaalutlusi, leidis komitee, et esildise 49 asjaomase ravimi korral 50st oleks lamba liha ja söödavate kudede keeluaja ühtlustamine 42 päevale konservatiivne lähenemisviis, et tagada tarbijate ohutus (st tagada, et tülosiinijäägid süstekohas oleksid alla liha ravimijääkide piirnormi (100 µg/kg)).
English: Therefore, the appropriateness of the withdrawal period for sheep of the reference product is uncertain.
Estonian: Sel põhjusel ei saa olla kindel, et võrdlusravimi keeluaeg lammastele on kohane.
English: In addition, JECFA at their 66th meeting reviewed tylosin and compared the residue depletion of tylosin in milk from cows and sheep (JECFA, 20068).The results show that tylosin residues deplete faster in milk from ewes, than in milk from cows.
Estonian: Lisaks vaatas JECFA oma 66. kohtumisel läbi tülosiini andmed ja võrdles tülosiinijääkide ammendumist lehma- ja lambapiimast (JECFA, 20068).
English: The proposed sheep meat withdrawal period for the generic product Tylovectin was 42 days, in line with the French reference product, Tylan 200.
Estonian: Geneerilisel ravimil Tylovectin oli kavandatud keeluaeg lambaliha korral 42 päeva, mis on kooskõlas Prantsusmaa võrdlusravimiga Tylan 200.
English: • on the basis of the available data, the CVMP considered the withdrawal periods for meat and offal, and milk derived from treated sheep should be amended to provide assurance for consumer safety for all concerned veterinary medicinal products, as referred in Annex I, except for Tilocen (marketing authorisation holder: A. Nikolakopoulos S.A);
Estonian: • Olemasolevatele andmetele põhjal järeldas veterinaarravimite komitee, et ravitud lammaste liha ja söödavate kudede ning piima keeluaegu tuleb muuta, et tagada tarbijate ohutus kõigi asjaomaste veterinaarravimite korral (vt I lisa), v.a ravimi Tilocen korral (müügiloa hoidja: A. Nikolakopoulos S.A).
English: The objective of this study was to evaluate kinetics, and the residual decline of tylosin in milk and plasma of lactating ewes, following a single intramuscular injection of tylosin at the dose of 10 mg/kg bw.
Estonian: Uuringu eesmärk oli hinnata tülosiini farmakokineetikat ja ravimijääkide vähenemist lakteerivate uttede piimas ja plasmas pärast tülosiini ühekordset intramuskulaarset süstet annuses 10 mg/kg.
English: The CVMP was requested to review all available residue depletion data for the veterinary medicinal products containing tylosin presented as a solution for injection for intramuscular use in sheep and recommend withdrawal periods for meat, offal and milk derived from treated sheep.
Estonian: Veterinaarravimite komiteel paluti läbi vaadata kõik olemasolevad ravimijääkide ammendumise andmed seoses veterinaarravimitega, mida turustatakse intramuskulaarsete süstelahustena lammastele ja mis sisaldavad tülosiini, ning soovitada ravitud lammaste liha, söödavate kudede ja piima keeluajad.
English: Having considered the grounds for referral and the data available, the CVMP concluded that for 49 out of 50 products, these being all those containing benzyl alcohol and propylene glycol as excipients, the withdrawal periods for meat and offal derived from treated sheep should be amended to 42 days, and the withdrawal periods for milk derived from treated sheep should be amended to 108 hours to provide assurance for consumer safety.
Estonian: Võttes arvesse esildise aluseid ja kättesaadavaid andmeid, järeldas veterinaarravimite komitee, et 49 ravimil 50st, mis kõik sisaldavad abiainetena bensüülalkoholi ja propüleenglükooli, tuleb ravitud lammaste liha ja söödavate kudede keeluaeg muuta 42 päevaks ning lambapiima keeluaeg 108 tunniks, et tagada tarbijate ohutus.
English: A GLP compliant residue depletion study was provided by one of the marketing authorisation holders involved in the procedure, and while a number of shortcoming on the study design were identified, the data allowed the recommendation to have a 42 day withdrawal period for meat and offal for 49 out of the 50 concerned products, i.e., for products containing 50 mg/ml and 200 mg/ml tylosin as a solution for injection for intramuscular use in sheep, containing benzyl alcohol and propylene glycol as excipients.
Estonian: Üks müügiloa hoidja, kes osales menetluses, esitas heale laboritava nõuetele vastava ravimijääkide ammendumise uuringu, ning kuigi uuringul oli mitu puudust, võimaldasid selle andmed siiski soovitada 49 asjaomasele ravimile 50st (lammaste intramuskulaarsed süstelahused, mis sisaldasid 50 mg/ml ja 200 mg/ml tülosiini ning abiainetena bensüülalkoholi ja propüleenglükooli) liha ja söödavate kudede 42 päevase keeluaja.
English: Residue depletion in sheep milk
Estonian: Ravimijääkide ammendumine lambapiimast
English: This represents a deposit at the injection site of approximately four times the amount of tylosin used in the residue study available, of 0.6 ml.
Estonian: See tähendab, et maht süstekohas oleks tülosiinijääkide uuringus kasutatud mahust (0,6 ml) ligikaudu neli korda rohkem.
English: In this study, however, additional shortcomings were identified, these being that the number of treated animals (n=3) was below the number required in VICH GL 484, animals were very young (12 kg mean bw), and also the sampling of the injection site did not include an outer ring sample.
Estonian: Uuringus tuvastati siiski veel puudusi, näiteks et ravitud loomade arv (n = 3) oli väiksem kui suunises VICH GL 48 nõutav arv4, loomad olid väga noored (keskmine kehamass 12 kg) ning süstekoha proovide hulgas ei olnud välisringi proovi.
English: While minor differences in concentrations of the same excipients have been considered not to have an impact on residue depletion, different solvents can have an effect on the viscosity of the formulations which can affect absorption.
Estonian: Kuigi on leitud, et samade abiainete kontsentratsiooni väikesed erinevused ei mõjuta ravimijääkide ammendumist, võivad eri lahustid muuta ravimite viskoossust, mis omakorda võib mõjutada imendumist.
English: For these 49 products, excipients listed are benzyl alcohol and propylene glycol, as well as small concentrations of different pH adjustors.
Estonian: Nende 49 ravimi abiained on bensüülalkohol ja propüleenglükool ning väikeses kontsentratsioonis mitmesugused pHregulaatorid.
English: For only one concerned product (Tilocen, marketing authorisation holder: A. Nikolakopoulos S.A), the solvent polyethylene glycol 400 is used instead of propylene glycol.
Estonian: Ainult ühes asjaomases ravimis (Tilocen, müügiloa hoidja: A. Nikolakopoulos S.A) kasutatakse lahustina propüleenglükooli asemel polüetüleenglükooli 400.
English: For these 49 products, excipients listed are benzyl alcohol and propylene glycol (in concentrations that differ slightly between products), as well as small concentrations of different pH adjustors.
Estonian: Nendes 49 ravimis on abiained bensüülalkohol ja propüleenglükool (eri ravimites veidi erinevas kontsentratsioonis) ning väikeses kontsentratsioonis ka eri pH-regulaatorid.
English: On the basis of a proprietary residue depletion study in sheep tissues, a withdrawal period for sheep meat and offal of 42 days could be derived for 49 concerned products.
Estonian: Ravimijääkide lammaste kudedes ammendumise ettevõttesisesest uuringust lähtudes võib 49 asjaomase ravimi jaoks kehtestada lamba liha ja söödavate kudede korral keeluaja 42 päeva.
English: Hence, data from this study could not be extrapolated to the only product containing the excipient polyethylene glycol 400 (Tilocen, marketing authorisation holder: A. Nikolakopoulos S.A), for the reason mentioned above.
Estonian: Seetõttu ei saa eespool nimetatud põhjustel selle uuringu andmeid ekstrapoleerida ainsa ravimi jaoks, mis sisaldab abiainet polüetüleenglükooli 400 (Tilocen, müügiloa hoidja: A. Nikolakopoulos S.A).
English: • no suitable residue depletion study was made available the results from which could be extrapolated to the concerned product Tilocen (marketing authorisation holder: A. Nikolakopoulos S.A) containing tylosin presented as solution for injection for use in the target species sheep, and containing polyethylene glycol 400 as excipient.
Estonian: • Ei esitatud ühtki sobivat ravimijääkide ammendumise uuringut, mida saaks ekstrapoleerida asjaomasele ravimile Tilocen (müügiloa hoidja: A. Nikolakopoulos S.A), mis on süstelahus, sisaldab tülosiini, on näidustatud kasutamiseks sihtliigil „lammas“ ja mis sisaldab abiainena polüetüleenglükooli 400.
English: For sheep milk, literature data showed that the tylosin residue depletion from sheep milk is faster than depletion from cow's milk.
Estonian: Lambapiima korral nähtub kirjandusandmetest, et tülosiinijääkide ammendumine lambapiimast on kiirem kui kadumine lehmapiimast.
English: Data from the literature indicated that the residue depletion from milk from sheep is faster than from milk from cows.
Estonian: Kirjandusandmed viitavad, et ravimijääkide ammendumine lambapiimast on kiirem kui lehmapiimast.
English: This study was conducted with the product Tylosin/Anafasis, containing benzyl alcohol and propylene glycol as excipients.
Estonian: Uuringul kasutati ravimit Tylosin/Anafasis, mis sisaldab abiainetena bensüülalkoholi ja propüleenglükooli.
English: Quality, target animal safety, user safety, and the environmental risk for the concerned veterinary medicinal products have not been assessed in this referral procedure.
Estonian: Esildises ei hinnatud asjaomaste veterinaarravimite kvaliteeti, ohutust sihtloomadel, kasutajate ohutust ega keskkonnariski.
English: While minor differences on concentrations of the same excipients have been considered not to have an impact on residue depletion from the injection site, different solvents can have an effect on the viscosity of the formulations, and consequently affect absorption of residues from the injection site.
Estonian: Kuigi eeldatakse, et samade abiainete kontsentratsiooni väikesed erinevused ei mõjuta ravimijääkide ammendumist süstekohast, võivad eri lahustid avaldada mõju ravimi viskoossusele ja seega mõjutada ravimijääkide imendumist süstekohast.
English: Therefore, the Committee considers that the benefit-risk balance for the veterinary medicinal product Tilocen (marketing authorisation holder: A. Nikolakopoulos S.A) containing tylosin presented as solution for injection for use in target species sheep, and containing polyethylene glycol 400 is not favourable in the absence of adequate residue depletion data in sheep to justify a withdrawal period of 42 days for sheep meat and offal, and 108 hours for sheep milk.
Estonian: Seepärast leiab komitee, et veterinaarravimi Tilocen (müügiloa hoidja: A. Nikolakopoulos S.A), mis on lammastel kasutatav tülosiini süstelahus ja mis sisaldab polüetüleenglükooli 400, kasulikkuse ja riski tasakaal ei ole soodne, sest puuduvad asjakohased ja piisavad ravimijääkide ammendumise andmed lammastel, et põhjendada lambaliha ja lammaste söödavate kudede keeluaega 42 päeva ning lambapiima keeluaega 108 tundi.
English: It has been noted that there are different approved withdrawal periods for sheep (milk, meat and offal) for veterinary medicinal products containing tylosin presented as solution for injection to be administered to sheep across the EU, e.g. sheep meat and offal from 8 days to 42 days; sheep milk from 4 days to 7 days.
Estonian: Märgitakse, et tülosiini sisaldavate süstelahuste heakskiidetud keeluajad lammastel (piim, liha ja söödavad koed) on eri ELi liikmesriikides erinevad, näiteks lamba liha ja söödavate kudede keeluaeg on 8…42 päeva ning lambapiima keeluaeg 4…7 päeva.
English: Overall summary of the scientific evaluation of veterinary medicinal products containing tylosin presented as solution for injection to be administered to sheep (see Annex I)
Estonian: Tülosiini sisaldavate lammastele süstelahusena manustatavate veterinaarravimite (vt I lisa) teadusliku hindamise üldkokkuvõte
English: Tylosin residues were detected in milk during the treatment, and were below the established MRL for tylosin in cattle milk (50 µg/kg) 36 hours after the last administration, and were not detected 48 hours after the last treatment dose.
Estonian: Piimas tuvastati ravi ajal tülosiinijäägid, mille kontsentratsioon oli 36 tundi pärast viimase annuse manustamist alla tülosiinijääkide piirnormi veisepiimas (50 µg/kg) ning puudusid 48 tundi pärast viimase annuse manustamist.
English: No proprietary residue depletion studies in ewes were submitted.
Estonian: Ei esitatud ühtki ettevõttesisest ravimijääkide ammendumise uuringut uttedel.
English: Cattle,
Estonian: Veised,
English: At day 21 after the last dose was administered, the residue concentrations in all samples of the injection site were below the established maximum residue limit (MRL) for tylosin in sheep meat of 100 µg/kg.
Estonian: 21. päeval pärast viimase annuse manustamist olid kõigis süstekoha proovides sisalduv ravimijääkide kontsentratsioon alla tülosiinijääkide piirnormi lambalihas (100 µg/kg).
English: Given that the viscosities of propylene glycol and polyethylene glycol 400 are different, a significant impact on the absorption and residue depletion from the injections site, and consequently on the withdrawal periods cannot be excluded.
Estonian: Et propüleenglükooli ja polüetüleenglükool 400 viskoossus on erinev, ei saa välistada olulist mõju ravimijääkide imendumisele süstekohast ja seetõttu ka keeluaegadele.
English: An additional risk mitigation measure of restricting the maximum injection volumes to 2.5 ml for sheep of 50 or less kg of bodyweight was considered by the CVMP.
Estonian: Veterinaarravimite komitee arutas täiendavat riskivähendusmeedet, mis piiraks kuni 50 kg kehamassiga lammastel suurimaks süstemahuks 2,5 ml.
English: The differences in concentrations of benzyl alcohol and propylene glycol, and in pH adjustors, have also been considered not to have an impact on residue absorption from tissues and the injection site.
Estonian: Samuti leiti, et bensüülalkoholi ja propüleenglükooli ning pH-regulaatori kontsentratsiooni erinevused ei mõjuta ravimijääkide imendumist kudedest ega süstekohast.
English: 5 CVMP note for guidance on the approach towards harmonisation of withdrawal periods (EMEA/CVMP/036/95) - link the influence of increasing the injection volume/site of injection on the absorption rate is difficult to quantify.
Estonian: 5 CVMP note for guidance on the approach towards harmonisation of withdrawal periods (EMEA/CVMP/036/95) - link
English: Nevertheless, it has been reported that the rate of absorption from the injection site depends on a number of factors (e.g. injection volume, excipients, lipophilicity of the active substance), and without specific residue data,
Estonian: On siiski andmeid, et süstekohast imendumise kiirus sõltub mitmest tegurist (nt süstemaht, abiained, toimeaine lipofiilsus) ja ilma ravimijääkide konkreetsete andmeteta on raske kvantifitseerida süstemahu / süstekohtade arvu suurendamise mõju imendumiskiirusele.
English: For one product (Tilocen), the solvent polyethylene glycol 400 was used instead of propylene glycol.
Estonian: Ühes ravimis (Tilocen) kasutati propüleenglükooli asemel lahustina polüetüleenglükooli 400.
English: Biovet JSC 39 Petar Rakov Str. 4550 Peshtera
Estonian: Prantsusmaa Biovet JSC 39 Petar Rakov Str.
English: All references to target species sheep should be deleted from the summary of product characteristics, labelling and package leaflet.
Estonian: Ravimi omaduste kokkuvõttest, märgistusest ja pakendi infolehelt tuleb kustutada kõik viited sihtliigile „lammas“.
English: • a GLP compliant residue study conducted with tylosin solution for injection, used intramuscularly in sheep was provided, and from which withdrawal periods could be established for meat and offal of treated sheep for 49 concerned products, i.e., those with excipients benzyl alcohol and propylene glycol.
Estonian: • Esitati hea laboritava nõuetele vastav ravimijääkide uuring, milles kasutati tülosiini intramuskulaarset süstelahust lammastel ja mille alusel saab määrata 49 asjaomase ravimi (ravimid, mis sisaldavad abiainetena bensüülalkoholi ja propüleenglükooli) keeluajad lambaliha ja lammaste söödavate kudede jaoks.
English: A half-life (T1/2) of approximately two days for the absorption from the injection site was determined from the available residue study.
Estonian: Olemasoleva ravimijääkide uuringu põhjal oli süstekohast imendumise poolväärtusaeg (T1/2) ligikaudu kaks ööpäeva.
English: Data from this study could not be used as a basis for extrapolating the withdrawal period for the only product containing the excipient polyethylene glycol 400 (Tilocen, marketing authorisation holder: A. Nikolakopoulos S.A), as differences between the absorption of residues from the injection site for these two products (i.e., given the differences on viscosities from products with different excipients) cannot be excluded, as mentioned in the section above.
Estonian: Uuringu andmete alusel ei saanud ekstrapoleerida ainsa abiainet polüetüleenglükooli 400 sisaldava ravimi (Tilocen, müügiloa hoidja: A. Nikolakopoulos S.A.) keeluaega, sest kummagi ravimi korral ei saa välistada ravimijääkide imendumise erinevusi süstekohast (eri abiainetega ravimite erineva viskoossuse tõttu), nagu on märgitud eelmises punktis.
English: For the product containing the excipient polyethylene glycol 400 (Tilocen, marketing authorisation holder: A. Nikolakopoulos S.A), no suitable residue depletion data are available for establishing a withdrawal period for sheep meat, offal, and milk.
Estonian: Abiainet polüetüleenglükooli 400 sisaldava ravimi korral (Tilocen, müügiloa hoidja: A. Nikolakopoulos S.A) puuduvad sobivad andmed ravimijääkide ammendumise kohta, et määrata keeluaeg lamba liha, söödavate kudede ja piima korral.
English: DOSAGE FOR EACH SPECIES, ROUTE AND METHOD OF ADMINISTRATION For sheep over 50 kg of bodyweight, the injection should be divided over two injection sites (maximum 2.5 ml injection volume per injection site).
Estonian: ANNUS IGA LIIGI, MANUSTAMISTEE JA MANUSTAMISVIISI PUHUL Üle 50 kg lammastel tuleb süstitav ravimi kogus jagada kahe süstekoha vahel (kuni 2,5 ml/süstekoht).
English: For sheep over 50 kg, however, the CVMP recommends that the dose is divided over two injection sites (maximum injection volume per site of 2.5 ml).
Estonian: Üle 50 kg lammaste korral soovitab veterinaarravimite komitee jagada annuse kahe süstekoha vahel (suurim süstemaht 2,5 ml/süstekoht).
English: • on the basis of the available data, the CVMP considered the withdrawal periods for meat and offal, and milk derived from treated sheep cannot be established for Tilocen (marketing authorisation holder: A. Nikolakopoulos S.A), as referred in Annex I.
Estonian: • Olemasolevate andmete alusel leidis veterinaarravimite komitee, et ravimiga Tilocen (müügiloa hoidja: A. Nikolakopoulos S.A; vt I lisa) ravitud lammaste liha ja söödavate kudede keeluaegu ei ole võimalik määrata.
English: From this study, the injection site was confirmed as the withdrawal period determining tissue.
Estonian: Uuringuga kinnitati, keeluaja kestust määrav kude on süstekoht.
English: For the product Tilocen (marketing authorisation holder: A. Nikolakopoulos S.A) containing tylosin presented as solution for injection for use in target species sheep, and containing polyethylene glycol 400, there was no data available that could be used to determine adequate withdrawal periods that could assure that after 42 days after treatment, the residues are below the established MRLs for tylosin in sheep.
Estonian: Puudusid andmed ravimi Tilocen (müügiloa hoidja: A. Nikolakopoulos S.A.) kohta, mis on lammastel kasutatav tülosiini süstelahus ja mis sisaldab polüetüleenglükooli 400, mille alusel oleks saanud määrata asjakohased ja piisavad keeluajad, mis tagaksid, et 42 päeva pärast ravi on ravimijääkide sisaldus lammastel alla tülosiinijääkide piirnormi.
English: However, as the injection site is the withdrawal period determining tissue, for the product containing polyethylene glycol 400 (Tilocen, marketing authorisation holder: A. Nikolakopoulos S.A), and in view of the effect of this excipient on product viscosity, a different rate of absorption of residues from the injection site cannot be ruled out.
Estonian: Süstekoht on keeluaja kestust määrav kude ja seepärast ei saa polüetüleenglükooli 400 sisaldava ravimi korral (Tilocen, müügiloa hoidja: A. Nikolakopoulos S.A), arvestades selle abiaine mõju ravimi viskoossusele, välistada teistsugust ravimijääkide süstekohast imendumise kiirust.
English: Given that the viscosities of propylene glycol and polyethylene glycol 400 are different, a significant impact on the absorption and residue depletion, and consequently on the withdrawal periods needed for tylosin solutions for injections with these different excipients cannot be excluded.
Estonian: Kuivõrd propüleenglükoolil on muu viskoossus kui polüetüleenglükoolil 400, ei saa välistada olulist mõju imendumisele ja ravimijääkide ammendumisele ning seega ei saa välistada ka võimalust, et eri abiainetega tülosiini süstelahuste keeluajad peavad olema erinevad.
English: The other submitted study was a GLP-compliant residue study with tylosin solution for injection, conducted in sheep via intramuscular administration.
Estonian: Teine esitatud uuring oli hea laboritava nõuetele vastav tülosiini intramuskulaarse süstelahuse ravimijääkide uuring lammastel.
English: The remaining product contains polyethylene glycol 400 instead of propylene glycol.
Estonian: Ülejäänud 1 ravim sisaldab propüleenglükooli asemel polüetüleenglükooli 400.
English: An additional safety factor of 30% was considered necessary in view of the limited number of animals treated (n=3), their weight (12 kg mean bw) and consequently the small injection volume required to treat these three lambs (0.6 ml), together with the lack of analysis of injection site ring samples, resulting in a withdrawal period of 28 days.
Estonian: Kuivõrd ravitud loomade arv (n = 3), loomade kehamass (12 kg) ja seega ka kolme noore lamba ravimiseks vajalik süstemaht (0,6 ml) olid väikesed ning et ei võetud süstekohavälisest ringist proove, peeti vajalikuks kasutada täiendavat 30% ohutustegurit, mistõttu saadi keeluajaks 28 päeva.
English: It is noted that a withdrawal period of 42 days for meat and offal is currently established for several of the products within this referral procedure.
Estonian: Tuleb märkida, et esildise mitme ravimi praegune keeluaeg liha ja söödavate kudede korral on 42 päeva.